These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Intravitreal ranibizumab versus bevacizumab for treatment of myopic choroidal neovascularization. Iacono P; Parodi MB; Papayannis A; Kontadakis S; Sheth S; Cascavilla ML; Bandello F Retina; 2012 Sep; 32(8):1539-46. PubMed ID: 22922846 [TBL] [Abstract][Full Text] [Related]
24. Health- and vision-related quality of life among patients with ocular histoplasmosis or idiopathic choroidal neovascularization at enrollment in a randomized trial of submacular surgery: Submacular Surgery Trials Report No. 5. Submacular Surgery Trials Research Group Arch Ophthalmol; 2005 Jan; 123(1):78-88. PubMed ID: 15642816 [TBL] [Abstract][Full Text] [Related]
25. One-year outcome of two different initial dosing regimens of intravitreal ranibizumab for myopic choroidal neovascularization. Kung YH; Wu TT; Huang YH Acta Ophthalmol; 2014 Dec; 92(8):e615-20. PubMed ID: 24924911 [TBL] [Abstract][Full Text] [Related]
26. Different dosing of intravitreal bevacizumab for choroidal neovascularization because of pathologic myopia. Wakabayashi T; Ikuno Y; Gomi F Retina; 2011 May; 31(5):880-6. PubMed ID: 21242860 [TBL] [Abstract][Full Text] [Related]
27. HOW VITREOMACULAR INTERFACE MODIFIES THE EFFICACY OF ANTI-VEGF THERAPY FOR MYOPIC CHOROIDAL NEOVASCULARIZATION. Iacono P; Battaglia Parodi M; Iuliano L; Bandello F Retina; 2018 Jan; 38(1):84-90. PubMed ID: 28098725 [TBL] [Abstract][Full Text] [Related]
28. [Intravitreal ranibizumab therapy for choroidal neovascularization secondary to pathological myopia]. Lukács R; Sándor G; Resch M; Szabó A; Barcsay G; Ecsedy M; Szepessy Z; Nagy ZZ; Papp A Orv Hetil; 2017 Apr; 158(15):579-586. PubMed ID: 28393596 [TBL] [Abstract][Full Text] [Related]
29. Vision-Related Quality of Life in Patients with Diabetic Macular Edema Treated with Intravitreal Aflibercept: The AQUA Study. Garweg JG; Stefanickova J; Hoyng C; Schmelter T; Niesen T; Sowade O; Sivaprasad S; Ophthalmol Retina; 2019 Jul; 3(7):567-575. PubMed ID: 31080168 [TBL] [Abstract][Full Text] [Related]
31. Real-world data on ranibizumab for myopic choroidal neovascularization due to pathologic myopia: results from a post-marketing surveillance in Japan. Ohno-Matsui K; Suzaki M; Teshima R; Okami N Eye (Lond); 2018 Dec; 32(12):1871-1878. PubMed ID: 30158574 [TBL] [Abstract][Full Text] [Related]